Lee, Catherine S <br/><br/>
Routine proteinuria monitoring for bevacizumab in patients with gynecologic malignancies.  [electronic resource] 

 -  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners  Dec 2016 
 - 771-776 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-092X 
<br/><br/><label>Standard No.: </label>10.1177/1078155215609987  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Bevacizumab--adverse effects<br/>Drug Monitoring--methods<br/>Female<br/>Genital Neoplasms, Female--diagnosis<br/>Humans<br/>Male<br/>Middle Aged<br/>Nephrotic Syndrome--chemically induced<br/>Proteinuria--chemically induced<br/>Retrospective Studies<br/>Risk Factors<br/>Urinalysis--methods